Skip to main content
. 2022 Aug 24;17(8):e0271926. doi: 10.1371/journal.pone.0271926

Table 8. Changes in death attitudes attributed to the experience among the Non-Drug, Psilocybin, LSD, Ayahuasca, and DMT groups1,2.

Non-Drug Psilocybin LSD Ayahuasca DMT
n = 933 n = 766 n = 904 n = 282 n = 307
Changes in fear of death (%)
    Decreased fear of death 88% 91%a 86%a 90%a 90%a
    Increased fear of death 5% 6%a 8%a 5%a 5%a
Curiosity or interest in death (%)
    Positive, desirable change 84% 84%a 80%a 84%a 81%a
    Negative, detrimental change 2% 2%a 3%a 2%a 2%a
Attitudes about death of others (%)
    Positive, desirable change 87% 86%a 84%a 90%a 82%a
    Negative, detrimental change 3% 2%a 3%a 1%a 4%a
Attitudes about own death (%)
    Positive, desirable change 90% 92%a 92%a 94%a 93%a
    Negative, detrimental change 3% 2%a 3%a 2%a 3%a
Death Attitudes Profile
    Mean change score3 for each factor (SD)
        Fear of death (e.g., “I have an intense fear of death.”) -2.32 (1.80) -2.13 (1.65)a -2.14 (1.70)a -1.97 (1.65)a -2.21 (1.62)a
        Neutral acceptance (e.g., “Death is neither good nor bad.”) 0.95 (1.22) 0.91 (1.05)a 0.95 (1.07) a 0.76 (.87)a 0.87 (1.00)a
        Death avoidance (e.g., “I avoid death thoughts at all costs.”) -2.01 (1.86) -1.45 (1.71) a -1.46 (1.75) a -1.30 (1.61) a -1.39 (1.49) a
        Approach acceptance (e.g., “I look forward to life after death.”) 1.13 (1.46) 0.58 (1.21) a,b 0.42 (1.32) a 0.68 (1.15) a,b 0.91 (1.31)b
        Escape acceptance (e.g., “I see death as a relief from the burden of this life.”) 0.27 (1.65) -0.33 (1.49) a -0.45 (1.63) a -0.66 (1.70) a -0.30 (1.43)a

1 Comparisons between drug groups for dichotomous outcomes were made using general linear model with a logit link and Type III sums of squares including covariates as described in text; continuous data were analyzed using ANOVA with the same covariates and Type III Sums of Squares; pairwise comparisons were adjusted using the Bonferroni method to control for Type I error rate.

2 Bold font = significant difference from the Non-Drug Group (p≤0.001); drug groups not sharing a common letter are significantly different (p≤0.001).

3 Participants rated attitudes before and after the experience on a 7-point Likert scale; negative change scores indicate a decrease in the rating on that scale from before to after and positive change scores indicate an increase from before to after.